- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: extended-release clonidine
Total 6425 results
-
Laboratorios Silanes S.A. de C.V.Completed
-
AstraZenecaRecruiting
-
Mylan Pharmaceuticals IncCompleted
-
Janssen Research & Development, LLCCompleted
-
ShionogiCompletedAttention Deficit Hyperactivity DisorderUnited States
-
University of RochesterTerminated
-
AstraZenecaCompleted
-
Turku University HospitalNot yet recruitingvHIT- and VOG-model for Bilateral Vestibular Neuronitis
-
Alcobra Ltd.CompletedADHD, Predominantly Inattentive TypeIsrael
-
Royal Brompton & Harefield NHS Foundation TrustCORDA, The Heart Charity; Apotex Inc.; The Cooley's Anemia Foundation,; The UK...UnknownBeta-ThalassemiaItaly
-
Woman'sPfizer; American Cancer Society, Inc.; Our Lady of the Lake Regional Medical...WithdrawnInsulin Resistance | Breast Cancer Stage | Racial BiasUnited States
-
University of MinnesotaCompletedKidney Transplant Failure and RejectionUnited States
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Cortria CorporationPPD; Pharmena North AmericaCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Damascus UniversityHama UniversityCompletedCross Bite | Orthodontic Appliance Complication | Class III MalocclusionSyrian Arab Republic
-
Boehringer IngelheimCompletedHIV InfectionsUnited States, Botswana, Germany, South Africa
-
Zogenix, Inc.Completed
-
Actavis Inc.Completed
-
Cao YuUnknownTherapeutic EquivalencyChina
-
Seoul National University HospitalCompleted
-
BioDelivery Sciences InternationalCompletedNeuropathy | Painful Diabetic Neuropathy | Diabetic NeuropathyUnited States
-
Duke UniversityTerminatedFatty LiverUnited States
-
Pauls Stradins Clinical University HospitalCompletedCoronary Artery Disease | Atherosclerosis | Prediabetic StateLatvia
-
Tris Pharma, Inc.CompletedAttention Deficit Hyperactivity DisorderUnited States
-
IPCA Laboratories Ltd.Completed
-
IPCA Laboratories Ltd.Completed
-
NYU Langone HealthHarvard Medical School (HMS and HSDM); National Institute on Drug Abuse (NIDA) and other collaboratorsRecruitingOpioid Use Disorder (OUD)United States
-
Actavis Inc.Completed
-
Medtronic DiabetesCompletedDiabetesUnited States
-
Cedars-Sinai Medical CenterVeloxis PharmaceuticalsActive, not recruitingKidney Transplant RejectionUnited States
-
Boehringer IngelheimCompletedParkinson DiseaseFrance, Germany, Netherlands
-
Royal Victoria Hospital, CanadaNot yet recruitingModerate to Severe Opioid Use DisorderCanada
-
Boehringer IngelheimCompleted
-
BiogenCompletedMultiple SclerosisSweden, United Kingdom, Netherlands, Belgium, Canada, Italy
-
Boehringer IngelheimCompleted
-
Actavis Inc.Completed
-
Actavis Inc.Completed
-
Brigham and Women's HospitalCompletedProstate CancerUnited States
-
Johnson & Johnson Consumer and Personal Products...Completed
-
Johnson & Johnson Consumer and Personal Products...McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.Completed
-
OnxeoSimbec ResearchCompletedHealthyUnited Kingdom
-
Addrenex Pharmaceuticals, Inc.Completed
-
Sarfez Pharmaceuticals, Inc.Sarfez Pharmaceuticals, Inc.Recruiting
-
University of FloridaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruiting